Hudson Bay Capital Management »

Kymera Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 23k 56.60
2025-06-30 $218k 5.0k 43.64

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Netflix Call Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Advanced Micro Devices Put Option (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Strategy Cl A New Call Option (MSTR)
Robinhood Mkts Com Cl A Call Option (HOOD)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Dollar Tree Call Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
FMR
BVF
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Driehaus Capital Management
Ubs Global Asset Management Americas

View all funds holding Kymera Therapeutics